J. Michael Bishop — oncogene researcher and Nobel laureate
American immunologist and microbiologist J. Michael Bishop (born 1936) won the 1989 Nobel Prize with Harold Varmus for discovering cellular origins of oncogenes and for work that transformed cancer biology.
Overview
John Michael Bishop (born February 22, 1936) is an American immunologist and microbiologist best known for his role in identifying the cellular origin of oncogenes. He shared the 1989 Nobel Prize in Physiology or Medicine with Harold Varmus for research that demonstrated how normal cellular genes can be converted into cancer-causing genes. Bishop has held long-term research and teaching positions at the University of California, San Francisco and remains influential in biomedical science. For additional biographical material see biographical resources.
Image gallery
2 Images
Key discoveries and concepts
Bishop and Varmus used comparative molecular methods to study retroviral oncogenes, notably revealing that the src gene carried by the Rous sarcoma virus has a counterpart in normal cells. They showed that the viral oncogene was derived from a cellular gene, establishing the concept of the proto-oncogene — a normal gene that can become oncogenic when altered. Their work clarified several mechanisms by which proto-oncogenes can be activated to drive malignant transformation, including mutation, chromosomal rearrangement, viral insertion, and environmental damage such as radiation or carcinogens.
Scientific approach and historical context
The Bishop–Varmus collaboration combined classical virology with emerging molecular biology techniques of the 1970s and 1980s. By comparing viral genomes with cellular DNA, they overturned a prevailing assumption that cancer-causing viral genes were unrelated to host genes. This shift reframed cancer as a genetic disease in which changes to the cell’s own genes play a central role. Their work is tied closely to the broader study of retroviruses and paved the way for molecular oncology as a discipline. Harold Varmus, Bishop’s co-recipient, is frequently discussed alongside him in histories of the discovery (co-winner information).
Impact, applications, and examples
- Conceptual: Introduced the proto-oncogene idea, altering how researchers think about tumor origins.
- Practical: Informed development of diagnostics that detect oncogene activation and helped spur targeted drug discovery aimed at specific signaling proteins, such as tyrosine kinases.
- Research: Enabled the mapping of signaling pathways that control cell growth, proliferation, and survival — foundations for many modern cancer therapies.
The influence of these findings extends beyond viruses, because many human cancers involve mutations in genes that are now understood as proto-oncogenes or tumor suppressors. Contemporary cancer biology, from molecular diagnostics to novel therapeutics, traces conceptual roots to the Bishop–Varmus discoveries (retroviral oncogene research).
Honors, legacy, and further reading
Bishop received major recognition for his contributions, including the 1989 Nobel Prize and earlier awards such as the 1984 Alfred P. Sloan Prize. He is widely cited for both his experimental work and his role as an educator and mentor. For summaries of the genetic mechanisms they described and their relevance to modern oncology, consult authoritative reviews and institutional profiles (additional resources).
Questions and answers
Q: Who is John Michael Bishop?
A: John Michael Bishop is an American immunologist and microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine with Harold Varmus and was co-winner of 1984 Alfred P. Sloan Prize. He currently serves as an active faculty member at the University of California, San Francisco.
Q: What is John Michael Bishop best known for?
A: John Michael Bishop is best known for his Nobel-winning work on retroviral oncogenes.
Q: What is retroviral oncogenes?
A: Retroviral oncogenes are genes that when activated can cause a normal cell to become a cancerous cell.
Q: Who did John Michael Bishop share the 1989 Nobel Prize with?
A: John Michael Bishop shared the 1989 Nobel Prize in Physiology or Medicine with Harold Varmus.
Q: What did John Michael Bishop discover with Harold Varmus in the 1980s?
A: Working with Varmus in the 1980s, John Michael Bishop discovered the first human oncogene, c-Src.
Q: How are malignant tumors formed according to John Michael Bishop's findings?
A: According to John Michael Bishop's findings, malignant tumors are formed from changes to the normal genes of a cell.
Q: What can cause changes to the normal genes of a cell according to John Michael Bishop's findings?
A: According to John Michael Bishop's findings, changes to the normal genes of a cell can be produced by viruses, by radiation, or by exposure to some chemicals.
Author
AlegsaOnline.com J. Michael Bishop — oncogene researcher and Nobel laureate Leandro Alegsa
URL: https://en.alegsaonline.com/art/140166